873573-64-9
Chemical Structure
MDAN-21
- CAS No.: 873573-64-9
- Formula:C58H71N7O12
- Molecular Weight:1058.22
InChIKey: LDGCYTJIXHBTBO-HATXQTAFSA-N
SMILES: O[C@]12[C@]34[C@](OC5=C(O)C=CC(C[C@@]2([H])N(CC4)CC6CC6)=C53)([H])C7=C(C8=CC=CC(NC(COCC(NCCCCCCCNC(COCC(N[C@@H]9[C@@]%10([H])[C@]%11%12C%13=C(C[C@](N(CC%12)C)([H])[C@@]%11(CC9)O)C=CC(O)=C%13O%10)=O)=O)=O)=O)=C8N7)C1
Biological Activity: MDAN-21 is a bivalent opioid ligand that contains both μ-opioid receptor agonists and δ-opioid receptor antagonists. MDAN-21 has a strong analgesic effect and does not produce tolerance in mouse studies. MDAN-21 can effectively inhibit the withdrawal of morphine dependent monkeys and alleviate abnormal pain in the study of rhesus monkeys. MDAN-21 can be used for the study of allodynia[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
MDAN-21 | MDAN-21 is a bivalent opioid ligand that contains both μ-opioid receptor agonists and δ-opioid receptor antagonists. MDAN-21 has a strong analgesic effect and does not produce tolerance in mouse studies. MDAN-21 can effectively inhibit the withdrawal of morphine dependent monkeys and alleviate abnormal pain in the study of rhesus monkeys. MDAN-21 can be used for the study of allodynia. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
